Buckle Isabelle

Biography

Prior to taking up her current position at Institut Pasteur, Isabelle was Global Vice-President Clinical Mass Spectrometry at Bruker Daltonics, her role being to propose innovative clinical solutions to opinion leaders and to identify future solutions. In 2010, Dr. Buckle was appointed Chief Executive Officer of InGen BioSciences, a group that is developing multiparameter tests for infectious diseases and distributing innovative in vitro diagnostic tests for clinical use. Before directing this group, she worked for five years as Director for Global Business Development for major pharmaceutical accounts at Applied Biosystems, which subsequently became Life Technologies (now Thermo Fisher). Prior to this role, Isabelle spent six years at Ciphergen Biosystems, an innovative, cutting-edge proteomics company, where she was Regional Director for Southern Europe, Belgium and Switzerland, then Head of Diagnostic Development for Europe, responsible for cooperation with clinical and pharmaceutical institutions. Before joining Ciphergen Biosystems, Dr. Buckle worked for nine years at Amersham Pharmacia Biotech (now GE), where she moved up through a variety of positions, ending up as European Sales and Marketing Director in the Non-industrial Chromatography Division. Isabelle Buckle holds a Master’s degree in Biochemistry and a PhD in Microbiology from the University of Paris VII, which she completed at the Institut Pasteur.

Research Interest

Bioinformatics & Systems Biology